Skip to content

Outcome of Cardiac Arrest Survivors

Outcome of Cardiac Arrest Survivors: Prospective Cohort of Ile-de-France

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02494414
Acronym
DESAC
Enrollment
601
Registered
2015-07-10
Start date
2015-07-24
Completion date
2021-01-22
Last updated
2026-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest Survivors

Keywords

Cardiac arrest, outcome, neurological status

Brief summary

Early prognosis of cardiac arrest - nearly 40000 new cases per year in France - has been extensively studied, highlighting a poor outcome (less than 8% at hospital discharge). However, little is known on mid and long-term prognostic factors and how these patients do survive from the event. Using a regional cohort, the aim of the study is to describe long-term survival rate of cardiac arrest survivors, and to assess the influence of treatment strategies on survival and functional outcome.

Detailed description

The collection of clinical and biological data of patients who experienced cardiac arrest and survive from hospital, including a regular follow-up with qualitative data (functional, neurological and quality of life) may provide important benchmark on the evolution of these patients and on the impact of acute interventions (such as cardio-pulmonary resuscitation, defibrillation, emergent coronary revascularization, neuroprotective treatments). Using a large identified cohort of survivors of cardiac arrest, we aim to describe the qualitative long-term prognosis of these cardiac arrest patients (functional, neurological and quality of life status). Secondarily, we intend to identify the long-term prognostic factors, and particularly the role of early interventions, using a long-term and qualitative combined endpoint (vital status, functional scales, SF36). This project is observational and will include all patients over 18 admitted alive after non-traumatic cardiac arrest in the area of Ile-de-France (France), whatever the cause of the cardiac arrest. Patients or their proxies, refusing their participation, will not be included. We will collect all pre- and in-hospital information related to the event and performs prospectively interviews at 3 months and every year anniversary. The questionnaire will include vital status, cardiovascular events, medication and a complete qualitative report (SF36, ADL scale, OPC, CPC, social-professional activities). This project will provide important data over time on the evolution of these patients. Findings will help in measuring the role of different strategies on long-term prognosis and consequently improve the overall management of cardiac arrest.

Interventions

Vital and neurological follow-up

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER
URC-CIC Paris Descartes Necker Cochin
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients alive after resuscitation from a out-of-hospital cardiac arrest * All causes for cardiac arrest * Age above 18 * Informed consent from the patient or next of kin

Exclusion criteria

* Impossibility for communication after hospital discharge, whatever the cause (language, residence…) * Follow-up refusal from the patient or next of kin

Design outcomes

Primary

MeasureTime frameDescription
Cerebral Performance Categories Scaleat last follow-up (48 months max)Combined vital and neurological status

Secondary

MeasureTime frameDescription
SF-36 (Short-Form General Health Survey)at last follow-up (48 months max)Quality of life
Overall Performance Categories (OPC)at last follow-up (48 months max)
Activities of Daily Living (ADL) scaleat last follow-up (48 months max)
New cardiovascular eventsat last follow-up (48 months max)
New York Heart Association (NYHA) statusat last follow-up (48 months max)

Countries

France

Contacts

STUDY_CHAIRJean-Philippe Empana, MD

INSERM U970 Centre de Recherche Cardiovasculaire de Paris Equipe 4, Epidémiologie Cardiovasculaire et Mort Subite

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 2, 2026